Proton-pump inhibitor use and the risk for community-acquired pneumonia

被引:207
|
作者
Sarkar, Monika [1 ]
Hennessy, Sean [1 ]
Yang, Yu-Xiao [1 ]
机构
[1] Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.7326/0003-4819-149-6-200809160-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies suggest that proton-pump inhibitors (PPIs) may increase the risk for community-acquired pneumonia (CAP). Objective: To examine the association between PPI use and CAP in adults followed in general practices in the United Kingdom. Design: Nested case-control study. Setting: The General Practice Research Database (1987 to 2002) in the United Kingdom. Participants: Patients age 18 years or older with at least 6 months of initial pneumonia-free follow-up in the database. Case patients (n = 80 066) were defined as those who received an incident diagnosis of CAP. Control participants (n = 799 881) were selected by using incidence density sampling, matching on practice site, calendar period, and follow-up duration. Measurements: Use of PPIs within 30 days before the index date. Adjusted odds ratios (ORs) were estimated by using conditional logistic regression, adjusting for potential confounders. Results: Overall, current PPI use was not associated with an increased risk for CAP (adjusted OR, 1.02 [95% CI, 0.97 to 1.08]) or risk for CAP that required hospitalization (adjusted OR, 1.01 [CI, 0.91 to 1.12]). There was a strong increase in risk for CAP associated with current use of PPI therapy that was started within the previous 2 days (adjusted OR, 6.53 [CI, 3.95 to 10.80]), 7 days (adjusted OR, 3.79 [CI, 2.66 to 5.42]), and 14 days (adjusted OR, 3.21 [CI, 2.46 to 4.18]), but there was no statistically significant association for longer-term current PPI therapy. A separate matched case-control analysis, which included the 3 strongest confounders as additional matching factors, yielded similar results as the primary analysis (adjusted OR, 0.96 [CI, 0.91 to 1.02]). Limitations: Adherence to PPI prescription was assumed to be 100%. No radiographic evidence was available to corroborate a diagnosis of CAP. Conclusion: Proton-pump inhibitor therapy started within the past 30 days was associated with an increased risk for CAP, whereas longer-term current use was not.
引用
收藏
页码:391 / W75
页数:10
相关论文
共 50 条
  • [1] Proton-pump inhibitor use and risk of community-acquired pneumonia in congenital heart disease patients
    Evers, Patrick D.
    Farkas, Dora K.
    Khoury, Michael
    Olsen, Morten
    Madsen, Nicolas L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2021, 4
  • [2] Proton-Pump Inhibitor Use and Risk of Community-Acquired Pneumonia in Congenital Heart Disease Patients
    Evers, Patrick D.
    Madsen, Nicolas
    Farkas, Dora
    Khoury, Michael
    PEDIATRICS, 2021, 147 (03)
  • [3] Confounding in the Association of Proton Pump Inhibitor Use With Risk of Community-Acquired Pneumonia
    Jena, Anupam B.
    Sun, Eric
    Goldman, Dana P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (02) : 223 - 230
  • [4] Confounding in the Association of Proton Pump Inhibitor Use With Risk of Community-Acquired Pneumonia
    Anupam B. Jena
    Eric Sun
    Dana P. Goldman
    Journal of General Internal Medicine, 2013, 28 : 223 - 230
  • [6] Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia
    Johnstone, J.
    Nerenberg, K.
    Loeb, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (11) : 1165 - 1177
  • [7] Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
    Lambert, Allison A.
    Lam, Jennifer O.
    Paik, Julie J.
    Ugarte-Gil, Cesar
    Drummond, M. Bradley
    Crowell, Trevor A.
    PLOS ONE, 2015, 10 (06):
  • [9] Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults
    Zirk-Sadowski, Jan
    Masoli, Jane A.
    Delgado, Joao
    Hamilton, Willie
    Strain, W. David
    Henley, William
    Melzer, David
    Ble, Alessandro
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (07) : 1332 - 1338
  • [10] Proton pump inhibitor use increases the risk of severe community-acquired infections
    Laheij, R. J. F.
    Targownik, L. E.
    Leung, S.
    Metge, C.
    van Oijen, M. G. H.
    Drenth, J. P. H.
    Jansen, J. B. M. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A31 - A31